Cause of death, by non-communicable diseases, ages 15-59, male in Late-demographic dividend
Late-demographic dividend: Cause of death, by non-communicable diseases, ages 15-59, male was 62.9% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 15-59, male in Late-demographic dividend, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 15-59.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 15-59, male in Late-demographic dividend stood at 62.9%.
That represents a change of down 4.4% on the previous year and down 2.9% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59, male in Late-demographic dividend peaked at 68.7% in 2019 and was at its lowest, 60.0%, in 2000.
That places Late-demographic dividend 10th out of 47 groups with data for 2021, putting it in the top quarter.
Cause of death, by non-communicable diseases, ages 15-59, male in Late-demographic dividend, year by year
| Year | % of total male deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 60.0% | — |
| 2010 | 64.8% | +7.9% |
| 2015 | 67.1% | +3.6% |
| 2019 | 68.7% | +2.4% |
| 2020 | 65.9% | -4.1% |
| 2021 | 62.9% | -4.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 60.0% | 60.0% | 60.0% | 1 |
| 2010s | 66.9% | 64.8% | 68.7% | 3 |
| 2020s | 64.4% | 62.9% | 65.9% | 2 |
Countries ranked near Late-demographic dividend
More health data for Late-demographic dividend
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 1.72 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0432 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 2.37 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0404 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, annual growth rate 1.83 % change on previous year (2025)
- Population ages 30-34, male, per capita 0.0376 units per person (2025)
- Population ages 25-29, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59, male in Late-demographic dividend?
- Cause of death, by non-communicable diseases, ages 15-59, male in Late-demographic dividend was 62.9% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59, male recorded in Late-demographic dividend?
- The highest recorded value was 68.7% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59, male recorded in Late-demographic dividend?
- The lowest recorded value was 60.0% in 2000.
- How does Late-demographic dividend rank for cause of death, by non-communicable diseases, ages 15-59, male?
- Late-demographic dividend ranks 10th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59, male rising or falling in Late-demographic dividend?
- Over the last ten years it is down 2.9%. The long-run trend across the full record is rising.
- Where does this Late-demographic dividend data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.